NCT03918798View on ClinicalTrials.gov

The Efficacy and Safety of Chloroprocaine 1% and 2% in Pediatric Population

PHASE2RecruitingINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

February 14, 2019

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
Hernia, InguinalFlat Foot
Interventions
DRUG

Chloroprocaine 1% Injectable Solution

All the eligible patients will be administrated by Chloroprocaine 1 % according to the randomization criteria.

DRUG

Chloroprocaine 2% Injectable Solution

All the eligible patients will be administrated by Chloroprocaine 1 % according to the randomization criteria.

Trial Locations (9)

10126

RECRUITING

Ospedale Infantile Santa Margherita di Torino Anestesia e Rianimazione Pediatrica, Turin

20122

TERMINATED

ASST Gaetano Pini CTO, Milan

20132

COMPLETED

Ospedale San Raffaele Anestesia e Rianimazione del distretto testacollo, Milan

46014

TERMINATED

Consorcio Hospital General Universitario De Valencia Cirugía Mayor Ambulatoria Y Cirugía General Y Del Aparato Digestivo, Valencia

46026

TERMINATED

Hospital Universitario Y Politecnico La Fe Cirugía Pediátrica Avda. Fernando Abril, Valencia

70126

RECRUITING

Ospedale Pediatrico Giovanni XXIII, Bari

00165

ACTIVE_NOT_RECRUITING

Ospedale Pediatrico Bambin Gesù di Roma Dipartimento di Emergenza Accettazione (DEA) e A.R.C.O, Rome

00168

ACTIVE_NOT_RECRUITING

Fondazione Policlinico Universitario Agostino Gemelli U.O.C. Anestesia delle Chirurgie Generali del Policlinico, Rome

06129

TERMINATED

Ospedale Universitario Santa Maria della Misericordia S.C. di Anestesia e Rianimazione 2, Perugia

All Listed Sponsors
lead

Sintetica SA

INDUSTRY